Clinical trial
Colchicine for Amyotrophic Lateral Sclerosis: a Phase II, Randomized, Double Blind, Placebo Controlled, Multicenter Clinical Trial
NCT03693781 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Modena as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Colchicine for Amyotrophic Lateral Sclerosis: a Phase II, Randomized, Double Blind, Placebo Controlled, Multicenter Clinical Trial
- Lead sponsor
- Azienda Ospedaliero-Universitaria di Modena
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 10, 2019
- Completion date
- January 3, 2023
- Enrollment
- 54 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.